• Home
  • News
  • AI
  • Cyber
  • GRC
  • Blogs
  • Live CVE
No Result
View All Result
Sumtrix
  • Home
  • News
  • AI
  • Cyber
  • GRC
  • Blogs
  • Live CVE
No Result
View All Result
Sumtrix
No Result
View All Result
Home AI

Phare Bio Clinches Newsweek’s AI Impact Award for Innovation Excellence

Jane Doe by Jane Doe
June 19, 2025
in AI
Phare Bio Clinches Newsweek’s AI Impact Award for Innovation Excellence
Share on FacebookShare on Twitter

Phare Bio, a pioneering biotech social venture, has been honored with Newsweek’s prestigious AI Impact Award for “Most Innovative Technology or Service.” This accolade celebrates Phare Bio’s innovative application of generative AI to revolutionize antibiotic discovery, directly addressing the urgent global health crisis of antimicrobial resistance (AMR).

The award recognizes Phare Bio’s innovative platform, developed in partnership with the renowned Collins Lab at MIT. This advanced technology is transforming the traditional drug discovery paradigm by designing entirely new classes of antibiotics.

To date, the collaboration has led to the discovery of three novel antibiotic classes, including the very first antibiotic ever identified using AI. These candidates are now being advanced toward preclinical development to combat some of the world’s most drug-resistant bacterial infections.

Read

App Store Power and Censorship: How Apple and Google Shape Your Digital Future

Google Sets Sights on Defying Gravity with Antigravity Project

Dr. Akhila Kosaraju, President and CEO of Phare Bio, expressed profound gratitude for the recognition. “This award from Newsweek is an incredible honor and a testament to what’s possible when we combine advanced AI with a commitment to bring urgently needed antibiotics to patients,” she stated.

“Antimicrobial resistance is a significant public health threat. Our goal is to rebuild the global antibiotic pipeline – and do it in a way that prioritizes innovation and urgency.”

What sets Phare Bio apart is its unique operational model as a nonprofit, committed to open-sourcing its AI models to democratize antibiotic discovery.

This distinctive approach has garnered significant support from various organizations, including funding from Google.org, The Audacious Project, and a substantial $27 million award from ARPA-H. The venture was also recently recognized on Fast Company’s 2025 World Changing Ideas list.

As antibiotic resistance continues to accelerate and conventional research and development struggles to keep pace, Phare Bio is demonstrating that open, AI-driven science can unlock the breakthroughs desperately needed.

This innovation offers new hope in the ongoing fight against superbugs and underscores the transformative potential of AI in addressing critical global challenges.

Previous Post

Huawei and China Telecom Secure 2025 TM Forum’s Excellence Award for Data and AI Innovation

Next Post

FDA Approval: AI-Driven Ultrasound Revolutionizes Pleural Effusion Detection

Jane Doe

Jane Doe

More Articles

MMaDA-Parallel: Advanced Multimodal Model Revolutionizing Content Generation
AI

MMaDA-Parallel: Advanced Multimodal Model Revolutionizing Content Generation

MMaDA-Parallel is a cutting-edge framework for multimodal content generation that departs from traditional sequential models by enabling parallel processing of...

by Jane Doe
November 19, 2025
ServiceNow AI Agents Vulnerable to Sophisticated Prompt Injection
AI

ServiceNow AI Agents Vulnerable to Sophisticated Prompt Injection

Attack Method: Researchers found second-order prompt injection attacks exploiting ServiceNow's Now Assist AI agents, leveraging their agent-to-agent discovery for unauthorized...

by Mayank Singh
November 19, 2025
European Union Introduces New Regulations Changing Data Privacy Landscape
AI

European Union Introduces New Regulations Changing Data Privacy Landscape

The European Union is implementing significant updates to its regulatory framework governing data privacy and automated decision-making. These new regulations,...

by Sumit Chauhan
November 19, 2025
Google Show Gemini 3: New Frontier in AI
AI

Google Show Gemini 3: New Frontier in AI

Google has officially launched Gemini 3, its latest leap forward in generative artificial intelligence technology. Positioned to compete at the...

by Sumit Chauhan
November 19, 2025
Next Post
FDA Approval: AI-Driven Ultrasound Revolutionizes Pleural Effusion Detection

FDA Approval: AI-Driven Ultrasound Revolutionizes Pleural Effusion Detection

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

Latest News

China Accuses US of Cyberattacks Using Microsoft Email Server Flaws

China Accuses US of Cyberattacks Using Microsoft Email Server Flaws

August 1, 2025
Online Scam Cases Continue to Rise Despite Crackdowns on Foreign Fraud Networks [Myanmar]

Online Scam Cases Continue to Rise Despite Crackdowns on Foreign Fraud Networks [Myanmar]

June 30, 2025
Stay Safe from Ransomware Using Skitnet Malware Techniques

Stay Safe from Ransomware Using Skitnet Malware Techniques

May 20, 2025
MMaDA-Parallel: Advanced Multimodal Model Revolutionizing Content Generation

MMaDA-Parallel: Advanced Multimodal Model Revolutionizing Content Generation

November 19, 2025
Anthropic Blocks AI Misuse for Cyberattacks

Anthropic Blocks AI Misuse for Cyberattacks

August 28, 2025
New VoIP Botnet Targets Routers Using Default Passwords

New VoIP Botnet Targets Routers Using Default Passwords

July 25, 2025
Aflac Incorporated Discloses Cybersecurity Incident

Aflac Incorporated Discloses Cybersecurity Incident

June 20, 2025
Sumtrix.com

© 2025 Sumtrix – Your source for the latest in Cybersecurity, AI, and Tech News.

Navigate Site

  • About
  • Contact
  • Privacy Policy
  • Advertise

Follow Us

No Result
View All Result
  • Home
  • News
  • AI
  • Cyber
  • GRC
  • Blogs
  • Live CVE

© 2025 Sumtrix – Your source for the latest in Cybersecurity, AI, and Tech News.

Our website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.